相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Genomic origin and EGFR-TKI treatments of pulmonary adenosquamous carcinoma
G. Lin et al.
ANNALS OF ONCOLOGY (2020)
Pembrolizumab - emerging treatment of pulmonary sarcomatoid carcinoma: A case report
Emanuela Cimpeanu et al.
WORLD JOURNAL OF CLINICAL CASES (2020)
Relationship Between Programmed Death Receptor-Ligand 1 Expression and Response to Checkpoint Inhibitor Immunotherapy in Pulmonary Sarcomatoid Carcinoma: A Pooled Analysis
Nalan A. Babacan et al.
CLINICAL LUNG CANCER (2020)
Mutation landscape and tumor mutation burden analysis of Chinese patients with pulmonary sarcomatoid carcinomas
Xiaohong Liang et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2019)
Poor prognosis of pulmonary sarcomatoid carcinoma with KRAS mutation and ALK fusion
Fangmin Chen et al.
ONCOTARGETS AND THERAPY (2019)
Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic
T. A. Chan et al.
ANNALS OF ONCOLOGY (2019)
Prevalence of MET exon 14 skipping mutation in pulmonary sarcomatoid carcinoma patients without common targetable mutations: A single-institute study
Yongfeng Yu et al.
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS (2019)
Oncogenic Signaling Pathways in The Cancer Genome Atlas
Francisco Sanchez-Vega et al.
CELL (2018)
KRAS mutation is predictive of outcome in patients with pulmonary sarcomatoid carcinoma
Mitra Mehrad et al.
HISTOPATHOLOGY (2018)
Identification of MET exon14 skipping by targeted DNA- and RNA-based next-generation sequencing in pulmonary sarcomatoid carcinomas
Yan Li et al.
LUNG CANCER (2018)
Laser microdissection: A powerful tool for genomics at cell level
Claudia Bevilacqua et al.
MOLECULAR ASPECTS OF MEDICINE (2018)
New therapeutic targets for pulmonary sarcomatoid carcinomas based on their genomic and phylogenetic profiles
Takahiro Nakagomi et al.
Oncotarget (2018)
Clinical and molecular characteristics of pulmonary sarcomatoid carcinoma
Jae Kyeom Sim et al.
KOREAN JOURNAL OF INTERNAL MEDICINE (2018)
Circulating tumor DNA analysis depicts subclonal architecture and genomic evolution of small cell lung cancer
Jingying Nong et al.
NATURE COMMUNICATIONS (2018)
Sarcomatoid carcinomas of the lung: a clinicopathological study of 86 cases with a new perspective on tumor classification
Annikka Weissferdt et al.
HUMAN PATHOLOGY (2017)
Pulmonary Sarcomatoid Carcinomas Commonly Harbor Either Potentially Targetable Genomic Alterations or High Tumor Mutational Burden as Observed by Comprehensive Genomic Profiling
Alexa B. Schrock et al.
JOURNAL OF THORACIC ONCOLOGY (2017)
Stepwise addition of genetic changes correlated with histological change from well-differentiated to sarcomatoid phenotypes: a case report
Taichiro Goto et al.
BMC CANCER (2017)
Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future
Nicholas McGranahan et al.
CELL (2017)
Characteristics and Prognostic Analysis of 69 Patients With Pulmonary Sarcomatoid Carcinoma
Yongbin Lin et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2016)
MET Amplification and Exon 14 Splice Site Mutation Define Unique Molecular Subgroups of Non-Small Cell Lung Carcinoma with Poor Prognosis
Joanna H. Tong et al.
CLINICAL CANCER RESEARCH (2016)
Next-Generation Sequencing of Pulmonary Sarcomatoid Carcinoma Reveals High Frequency of Actionable MET Gene Mutations
Xuewen Liu et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Deep Sequencing Analysis Reveals That KRAS Mutation Is a Marker of Poor Prognosis in Patients with Pulmonary Sarcomatoid Carcinoma
Filippo Lococo et al.
JOURNAL OF THORACIC ONCOLOGY (2016)
Predictive biomarkers for checkpoint inhibitor-based immunotherapy
Geoffrey T. Gibney et al.
LANCET ONCOLOGY (2016)
Molecular characterization of pulmonary sarcomatoid carcinoma: analysis of 33 cases
Simone B. S. P. Terra et al.
MODERN PATHOLOGY (2016)
High-throughput somatic mutation profiling in pulmonary sarcomatoid carcinomas using the LungCarta™ Panel: exploring therapeutic targets
V. Fallet et al.
ANNALS OF ONCOLOGY (2015)
Programmed death-1 ligand 1 and 2 are highly expressed in pleomorphic carcinomas of the lung: Comparison of sarcomatous and carcinomatous areas
Sehui Kim et al.
EUROPEAN JOURNAL OF CANCER (2015)
The 2015 World Health Organization Classification of Lung Tumors Impact of Genetic, Clinical and Radiologic Advances Since the 2004 Classification
William D. Travis et al.
JOURNAL OF THORACIC ONCOLOGY (2015)
Clonal status of actionable driver events and the timing of mutational processes in cancer evolution
Nicholas McGranahan et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
PyClone: statistical inference of clonal population structure in cancer
Andrew Roth et al.
NATURE METHODS (2014)
Efficacy of First-Line Chemotherapy in Patients with Advanced Lung Sarcomatoid Carcinoma
Thibault Vieira et al.
JOURNAL OF THORACIC ONCOLOGY (2013)
Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples
Kristian Cibulskis et al.
NATURE BIOTECHNOLOGY (2013)
CONTRA: copy number analysis for targeted resequencing
Jason Li et al.
BIOINFORMATICS (2012)
Multiparametric molecular characterization of pulmonary sarcomatoid carcinoma reveals a nonrandom amplification of anaplastic lymphoma kinase (ALK) gene
Giuseppe Pelosi et al.
LUNG CANCER (2012)
Outcomes of sarcomatoid carcinoma of the lung: A Surveillance, Epidemiology, and End Results database analysis
Sai Yendamuri et al.
SURGERY (2012)
EGFR and p53 Status of Pulmonary Pleomorphic Carcinoma: Implications for EGFR Tyrosine Kinase Inhibitors Therapy of an Aggressive Lung Malignancy
Yih-Leong Chang et al.
ANNALS OF SURGICAL ONCOLOGY (2011)
Identification of EGFR mutations in lung sarcomatoid carcinoma
Alvaro Leone et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Incidence of EGFR Exon 19 Deletions and L858R in Tumor Specimens From Men and Cigarette Smokers With Lung Adenocarcinomas
Sandra P. D'Angelo et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Pulmonary Sarcomatoid Carcinomas: A Practical Overview
Giuseppe Pelosi et al.
INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY (2010)
Pulmonary Pleomorphic Carcinoma A Clinicopathological Study Including EGFR Mutation Analysis
Kyoichi Kaira et al.
JOURNAL OF THORACIC ONCOLOGY (2010)
Fast and accurate short read alignment with Burrows-Wheeler transform
Heng Li et al.
BIOINFORMATICS (2009)
EGFR and KRAS status of primary sarcomatoid carcinomas of the lung: Implications for anti-EGFR treatment of a rare lung malignancy
Antoine Italiano et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
BreakDancer: an algorithm for high-resolution mapping of genomic structural variation
Ken Chen et al.
NATURE METHODS (2009)
Sarcomatoid carcinoma of the lung: A predictor of poor prognosis
Linda W. Martin et al.
ANNALS OF THORACIC SURGERY (2007)
Sarcomatoid carcinomas of the lung - are these histogenetically heterogeneous tumors?
Markus Blaukovitsch et al.
VIRCHOWS ARCHIV (2006)
分享论文
